## Abstract An efficient and practical __ex vivo__ expansion methodology for human hematopoietic stem/progenitor cells (HSPCs) is critical in realizing the potential of HSPC transplantation in treating a variety of hematologic disorders and as a supportive therapy for malignant diseases. We report
Immunodeficient mice as models of human hematopoietic stem cell engraftment
β Scribed by Mo A Dao; Jan A Nolta
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 65 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0952-7915
No coin nor oath required. For personal study only.
β¦ Synopsis
The past year has brought forth some exciting developments in the use of murine xenotransplantation systems to study the biology and transduction of human hematopoietic stem cells. The effects of cytokines have been studied by injection into the mice or by treatment of the cell inoculum prior to injection. The importance of the cell cycle and integrin expression has been evaluated. New methods of gene therapy have been tested in xenograft models -including cell cycle manipulation and a promising new lentiviral vector system, based on HIV.
π SIMILAR VOLUMES
## Abstract In this study, __in vivo__ studies, both nude mouse and rabbit cartilage defect, were tested for chondrogenesis using stem cells (SCs) using growth factor. Specifically, human mesenchymal stem cells (hMSCs) were embedded in a hydrogel scaffold, which was coencapsulated with transforming
## Abstract ## Objective To construct a humanized mouse model of systemic lupus erythematosus (SLE) that resembles the human disease in order to define the pathophysiology and targets for treatments. ## Methods We infused peripheral blood mononuclear cells (PBMCs) from SLE patients into BALBβ RA